These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 16200212

  • 1. Reversal of experimental pulmonary hypertension by PDGF inhibition.
    Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F.
    J Clin Invest; 2005 Oct; 115(10):2811-21. PubMed ID: 16200212
    [Abstract] [Full Text] [Related]

  • 2. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling.
    Klein M, Schermuly RT, Ellinghaus P, Milting H, Riedl B, Nikolova S, Pullamsetti SS, Weissmann N, Dony E, Savai R, Ghofrani HA, Grimminger F, Busch AE, Schäfer S.
    Circulation; 2008 Nov 11; 118(20):2081-90. PubMed ID: 18955668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
    Zeng Z, Li Y, Jiang Z, Wang C, Li B, Jiang W.
    Cardiovasc Ther; 2010 Nov 11; 28(1):23-9. PubMed ID: 20074256
    [Abstract] [Full Text] [Related]

  • 5. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W, Grimminger F.
    Circ Res; 2004 Apr 30; 94(8):1101-8. PubMed ID: 15031263
    [Abstract] [Full Text] [Related]

  • 6. Implication of PDGF signaling in cigarette smoke-induced pulmonary arterial hypertension in rat.
    Xing AP, Hu XY, Shi YW, Du YC.
    Inhal Toxicol; 2012 Jul 30; 24(8):468-75. PubMed ID: 22746397
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Ikeda T, Nakamura K, Akagi S, Kusano KF, Matsubara H, Fujio H, Ogawa A, Miura A, Miura D, Oto T, Yamanaka R, Otsuka F, Date H, Ohe T, Ito H.
    J Cardiovasc Pharmacol; 2010 Jan 30; 55(1):39-48. PubMed ID: 19786891
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PDGF and microvessel wall remodeling in adult rat lung: imaging PDGF-AA and PDGF-Ralpha molecules in progenitor smooth muscle cells developing in experimental pulmonary hypertension.
    Jones R, Capen D, Jacobson M, Munn L.
    Cell Tissue Res; 2006 Dec 30; 326(3):759-69. PubMed ID: 16794827
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.
    Yoshiji H, Kuriyama S, Noguchi R, Ikenaka Y, Yoshii J, Yanase K, Namisaki T, Kitade M, Yamazaki M, Asada K, Akahane T, Tsujimoto T, Uemura M, Fukui H.
    Int J Mol Med; 2006 May 30; 17(5):899-904. PubMed ID: 16596278
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E, Hongo M, Sakai A, Terasawa F, Takahashi M, Yazaki Y, Kinoshita O, Ikeda U.
    Clin Exp Pharmacol Physiol; 2007 Jul 30; 34(7):594-600. PubMed ID: 17581214
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Concurrent rho-kinase and tyrosine kinase platelet-derived growth factor inhibition in experimental pulmonary hypertension.
    Jasińska-Stroschein M, Owczarek J, Plichta P, Orszulak-Michalak D.
    Pharmacology; 2014 Jul 30; 93(3-4):145-50. PubMed ID: 24662671
    [Abstract] [Full Text] [Related]

  • 17. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S, Ellinghaus P, Janssen W, Kramer F, Lustig K, Milting H, Kast R, Klein M.
    Cardiovasc Res; 2009 Apr 01; 82(1):30-9. PubMed ID: 19131365
    [Abstract] [Full Text] [Related]

  • 18. Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
    van Albada ME, Berger RM, Niggebrugge M, van Veghel R, Cromme-Dijkhuis AH, Schoemaker RG.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):107-16. PubMed ID: 16978602
    [Abstract] [Full Text] [Related]

  • 19. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP, Okida A, Higuchi M, Yamano Y, Hikasa Y.
    Vascul Pharmacol; 2018 Jan 07; 100():41-50. PubMed ID: 29100963
    [Abstract] [Full Text] [Related]

  • 20. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J, Taskinen E, Von Willebrand E.
    Transplantation; 2003 Apr 27; 75(8):1147-53. PubMed ID: 12717194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.